SonoScape Medical Corp
SZSE:300633

Watchlist Manager
SonoScape Medical Corp Logo
SonoScape Medical Corp
SZSE:300633
Watchlist
Price: 30.63 CNY -1.83% Market Closed
Market Cap: 13.3B CNY
Have any thoughts about
SonoScape Medical Corp?
Write Note

SonoScape Medical Corp
Short-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SonoScape Medical Corp
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
SonoScape Medical Corp
SZSE:300633
Short-Term Debt
ÂĄ311.5m
CAGR 3-Years
135%
CAGR 5-Years
4%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Short-Term Debt
ÂĄ70m
CAGR 3-Years
88%
CAGR 5-Years
46%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Short-Term Debt
ÂĄ428.7m
CAGR 3-Years
24%
CAGR 5-Years
33%
CAGR 10-Years
24%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Short-Term Debt
ÂĄ3.5m
CAGR 3-Years
N/A
CAGR 5-Years
-15%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Short-Term Debt
ÂĄ338.8m
CAGR 3-Years
N/A
CAGR 5-Years
76%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Short-Term Debt
ÂĄ328.2m
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

SonoScape Medical Corp
Glance View

Market Cap
13.2B CNY
Industry
Health Care

SonoScape Medical Corp, a company entrenched in the realm of medical technology, weaves its story around innovation and dedication in the healthcare sector. Founded in 2002, this Shenzhen-based company has become a global player in the development and production of medical equipment, particularly in the field of ultrasound and endoscopy. At its core, SonoScape melds cutting-edge technology with practical healthcare applications, aiming to improve diagnostic accuracy and patient outcomes. With its R&D centers rich in technical prowess and creativity, SonoScape continuously pushes forward the boundaries of medical imaging, offering a diverse range of ultrasound systems that cater to various clinical needs and environments. Revenue for SonoScape Medical Corp stems largely from the sale of these high-precision medical devices, which are marketed both domestically within China and internationally. The company thrives on the ever-growing demand for advanced healthcare solutions, ensuring a steady stream of income through its robust distribution channels across numerous countries. In addition to equipment sales, SonoScape provides comprehensive after-sales service packages, ensuring customer satisfaction and fostering long-term relationships with healthcare institutions. By maintaining a strong focus on innovation while meeting industry standards and regulations, SonoScape not only solidifies its financial standing but also enhances its reputation as a significant contributor to the global healthcare landscape.

Intrinsic Value
49.55 CNY
Undervaluation 38%
Intrinsic Value
Price

See Also

What is SonoScape Medical Corp's Short-Term Debt?
Short-Term Debt
311.5m CNY

Based on the financial report for Sep 30, 2024, SonoScape Medical Corp's Short-Term Debt amounts to 311.5m CNY.

What is SonoScape Medical Corp's Short-Term Debt growth rate?
Short-Term Debt CAGR 5Y
4%

Over the last year, the Short-Term Debt growth was 188%. The average annual Short-Term Debt growth rates for SonoScape Medical Corp have been 135% over the past three years , 4% over the past five years .

Back to Top